136 related articles for article (PubMed ID: 23835953)
1. Siglec-8 in induced sputum of COPD patients.
Mroz RM; Holownia A; Wielgat P; Sitko A; Skopinski T; Chyczewska E; Braszko JJ
Adv Exp Med Biol; 2013; 788():19-23. PubMed ID: 23835953
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients.
Wielgat P; Mroz RM; Stasiak-Barmuta A; Szepiel P; Chyczewska E; Braszko JJ; Holownia A
Adv Exp Med Biol; 2015; 839():1-5. PubMed ID: 25252903
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients.
Holownia A; Mroz RM; Skopinski T; Kolodziejczyk A; Chyczewska E; Braszko JJ
Adv Exp Med Biol; 2013; 756():9-14. PubMed ID: 22836613
[TBL] [Abstract][Full Text] [Related]
4. Altered histone deacetylase activity and iNOS expression in cells isolated from induced sputum of COPD patients treated with tiotropium.
Holownia A; Mroz RM; Wielgat P; Skopinski T; Kolodziejczyk A; Sitko A; Chyczewska E; Braszko JJ
Adv Exp Med Biol; 2013; 788():1-6. PubMed ID: 23835951
[TBL] [Abstract][Full Text] [Related]
5. Tregs and HLA-DR expression in sputum cells of COPD patients treated with tiotropium and formoterol.
Holownia A; Wielgat P; Stasiak-Barmuta A; Kwolek A; Jakubow P; Szepiel P; Chyczewska E; Braszko JJ; Mroz RM
Adv Exp Med Biol; 2015; 839():7-12. PubMed ID: 25315616
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients.
Holownia A; Mroz RM; Skopinski T; Kielek A; Kolodziejczyk A; Chyczewska E; Braszko JJ
Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):64-7. PubMed ID: 21147623
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
[TBL] [Abstract][Full Text] [Related]
8. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
Szmidt M
Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
[TBL] [Abstract][Full Text] [Related]
9. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
11. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender.
Tashkin DP; Varghese ST
Pulm Pharmacol Ther; 2011 Feb; 24(1):147-52. PubMed ID: 20659577
[TBL] [Abstract][Full Text] [Related]
14. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
[TBL] [Abstract][Full Text] [Related]
16. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
[TBL] [Abstract][Full Text] [Related]
18. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.
Meyer T; Reitmeir P; Brand P; Herpich C; Sommerer K; Schulze A; Scheuch G; Newman S
Respir Med; 2011 Jun; 105(6):900-6. PubMed ID: 21397483
[TBL] [Abstract][Full Text] [Related]
19. Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.
Ge L; Wang N; Chen Z; Xu S; Zhou L
Cytokine; 2024 May; 177():156558. PubMed ID: 38412768
[TBL] [Abstract][Full Text] [Related]
20. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
